Globus Medical (GMED) Sees IPO Price of $16-$18/Share
Tweet
Share
E-mailGet Alerts GMED Hot Sheet
Join SI Premium – FREE
In an amended S-1 filing Tuesday, Globus Medical (NYSE: GMED) disclosed it will offer 11,764,705 shares at a price ranging from $16-$18 per share. Globus plans to list on the New York Stock Exchange under the ticker, "GMED."
The offering is being made through BofA Merrill Lynch, Goldman, Sachs & Co., Piper Jaffray, Leerink Swann, Canaccord Genuity, William Blair & Company, and Oppenheimer & Co.
Globus Medical a medical device company focused exclusively on the design, development and commercialization of products that promote healing in patients with spine disorders.
The offering is being made through BofA Merrill Lynch, Goldman, Sachs & Co., Piper Jaffray, Leerink Swann, Canaccord Genuity, William Blair & Company, and Oppenheimer & Co.
Globus Medical a medical device company focused exclusively on the design, development and commercialization of products that promote healing in patients with spine disorders.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Viking Therapeutics prices $500M stock and convertible notes offering
- Leader's Advantage Acquisition Corp. closes $150M IPO on Nasdaq
- SK Hynix's Solidigm eyes 2027 IPO at value up to $150 billion - Reuters
Create E-mail Alert Related Categories
IPOsRelated Entities
Piper Jaffray, William Blair, S1, Canaccord GenuitySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
